Paclitaxel and Ritonavir: Drug Interaction Guide

Quick answer: This is a major interaction — avoid combining Paclitaxel and Ritonavir unless specifically directed by your doctor.

Interaction severity: Major — avoid combination

How Paclitaxel interacts with Ritonavir

Ritonavir strongly inhibits CYP3A4 and P-glycoprotein, potentially increasing paclitaxel exposure and severe haematological or neurological toxicity.

What you should do

Avoid the combination when possible and involve oncology and HIV specialists in selecting alternatives. If unavoidable, use intensive toxicity and blood-count monitoring with protocol-directed dose adjustment.

Key facts

Severity

Major — avoid combination

Mechanism

Ritonavir strongly inhibits CYP3A4 and P-glycoprotein, potentially increasing paclitaxel exposure and severe haematologi...

Action

Avoid the combination when possible and involve oncology and HIV specialists in selecting alternatives. If unavoidable, ...

Important medical disclaimer: This page provides educational information about drug interactions for general reference. It is not a substitute for professional medical advice, diagnosis, or treatment. Always discuss your specific medications with a qualified healthcare provider before starting, stopping, or changing any treatment. About our editorial team.

Frequently asked questions

Can I take Paclitaxel and Ritonavir together?

No — this combination should generally be avoided. Avoid the combination when possible and involve oncology and HIV specialists in selecting alternatives. If unavoidable, use intensive toxicity and blood-count monitoring with protocol-directed dose adjustment.

What is the severity of this interaction?

The interaction between Paclitaxel and Ritonavir is classified as Major — avoid combination. Ritonavir strongly inhibits CYP3A4 and P-glycoprotein, potentially increasing paclitaxel exposure and severe haematological or neurological toxicity.

What should I do if I'm prescribed both?

Avoid the combination when possible and involve oncology and HIV specialists in selecting alternatives. If unavoidable, use intensive toxicity and blood-count monitoring with protocol-directed dose adjustment. Always consult your prescribing clinician — do not stop or change medications without medical guidance.

Last reviewed: by iMedic Medical Editorial Team. Our editorial process.